Drawing for VITAPHARMA

USPTO serial 74371166

VITAPHARMA

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
PORTER, KATHLEEN C.
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VITAPHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joseph A. DeGrandi

JOSEPH A DEGRANDI1850 M ST NW STE 800WASHINGTON, DC 20036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003cosmetics; namely, perfume, body lotions, skin lotions and cremes, bath and toilet soaps, cream bath, shampoos, hair lotions, dentrifices, throat sprays and mouthwashes for non-medical use and breath freshenersABANDONED—
005phamaceuticals preparations; namely, anorectics for the treatment of anorexia, analgetics/antirheumatics for the treatment of pains, antiallergics for the treatment of allergic diseases, antidotes for the treatment of toxicity and poisoning, antiemetics/antivertiginousics for the treatment of hyperemesis, vomiting, motion sickness, antihypertonics (antihypertensives) for the treatment of hypertension, antitussives/expectorants for treatment of all kind of coughs and mucous diseases, balneotherapeutics for the treatment of dermatopathy, dermatitis, betablockers used in the treatment of cardiac and cardiovascular diseases, calcium antagonists used in the treatment of cardiac and cardiovascular diseases, ace-inhibitors used in the treatment of cardiac and cardiovascular diseases, broncholytics/antiasthmatics used in the treatment of diseases of the respiratory tract, dermatics used in the treatment of all kinds of dermatic diseases, diagnostics reagents for clinical or medical laboratory use, diuretics for treatment of diuresis and hypertension, cardioactive agents used for the treatment of cardiac and cardiovascular diseases, coronary agents (vasodilators) for use in the treatment of coronary heart diseases, hepatica agents for use in the treatment of hepatic diseases, gastrointestinal agents for use in the treatment of gastrointestinal diseases, migraine agents for use in the treatment of migraine and headaches, mouth and throat therapeutics, muscle relaxants, ophtalmics for use in the treatment of ophtalmic diseases, preparations for the treatment of Parkinson's diseases and against extrapyramidal disorders, psychotropic drugs for the treatment of psychotrpic and psychotic diseases, rhinologics for use in the treatment of diseases of the respiratory tract, thyroid therapeutics, sera for clinical or medical laboratory use, immunoglobins for clinical or medical laboratory use, vaccines for use in the prevention of viral influenza for human use, sexual hormones and their inhibitors, cytostatic agents for use in the treatment of cancer, oncosis and carcinolysis, vitamin and mineral supplementals, and phytotherapeutics for use in the treatment of all kinds of inflammatory diseases as well as dermatic diseasesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 30, 1994ABN1ABANDONMENT - EXPRESS MAILED—
Aug 17, 1994CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 1, 1994CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 20, 1993CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 24, 1993CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 15, 1993DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance